The significant cost of systematic reviews and meta-analyses: A call for greater involvement of machine learning to assess the promise of clinical trials-Reference-Cited by-同舟云学术

The significant cost of systematic reviews and meta-analyses: A call for greater involvement of machine learning to assess the promise of clinical trials

Published:2019-12 Issue: Volume:16 Page:100443
ISSN:2451-8654
Container-title:Contemporary Clinical Trials Communications
language:en
Short-container-title:Contemporary Clinical Trials Communications

Author:

Michelson Matthew,Reuter Katja

Funder

NIH

Evid Science

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference29 articles.

1. Drugs, devices, and the FDA: Part 1: an overview of approval processes for drugs;Van Norman;JACC Basic Transl Sci,2016

2. Validating therapeutic targets through human genetics;Plenge;Nat. Rev. Drug Discov.,2013

3. “Right-to-Try” legislation: progress or peril?;Yang;J. Clin. Orthod.,2015

4. Drugs, devices, and the FDA: Part 2: an overview of approval processes: FDA approval of medical devices;Van Norman;JACC Basic Transl Sci,2016

5. Consider drug efficacy before first-in-human trials;Kimmelman;Nature,2017

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LLMscreen: A Python Package for Systematic Review Screening of Scientific Texts Using Prompt Engineering;2024-09-11

2. Meta-mistake: are fragile meta-analyses in ophthalmology worth the high cost?;Eye;2024-09-09

3. Loon Lens 1.0 Validation: Agentic AI for Title and Abstract Screening in Systematic Literature Reviews;2024-09-06

4. Combining Semantic Matching, Word Embeddings, Transformers, and LLMs for Enhanced Document Ranking: Application in Systematic Reviews;Big Data and Cognitive Computing;2024-09-04

5. Artificial intelligence applied in human health technology assessment: a scoping review protocol;JBI Evidence Synthesis;2024-09-03